PRISM MEDICO AND PHARMACY LTD. - 512217 - Detailed Public Statement
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement for the attention of the Equity Shareholders of Prism Medico and Pharmacy Ltd ("Target Company"). PRISM MEDICO AND PHARMACY LTD. - 512217 - Open Offer
Navigant Corporate Advisors Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulation 3(1), Regulation 4 read with Regulation 15(1) and Regulation 13 and Regulation 14 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the attention of the Equity Shareholders of Prism Medico and Pharmacy Ltd ("Target Company"). PRISM MEDICO AND PHARMACY LTD. - 512217 - Clarification/Resubmission - Outcome Of Board Meeting Held On 14Th November, 2022.
With reference to the above captioned subject, it is hereby submitted that due to the inadvertent mistake/oversight, the complete file of the financial results relating to the quarter and half year ended 30th September, 2022 could not be uploaded on the website of the stock exchange. We really regret for furnishing the said details and now to set the records right, we enclose herewith the complete financial results. Kindly acknowledge the receipt and oblige. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that theBoard of Directors at their meeting held today (i.e. 14thNovember, 2022) whichcommenced at 04:30 P.M. and concluded at 06:00 P.M. have inter alia approved the following: ? The Board considered and approved the Un-Audited Standalone Financial Results of the company for the quarter and half year ended 30thSeptember, 2022 alongwith Limited Review Report duly signed by the Auditors of the company. PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for Intimation Of Board Meeting.
PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as 'the Company') is scheduled to be held at the registered office of the company i.e. Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 on Monday, the 14th day of November, 2022 at 04:30 P.M. inter alia, to: - Consider, approve and take on record the Un-Audited Financial Results of the company along with the Limited Review Report for the quarter and half year ended as on 30th September, 2022, as per Regulation 33 of the Listing Regulations. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. PRISM MEDICO AND PHARMACY LTD. - 512217 - Undertaking Of Functional Website.
This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The website address of the company is https://www.prismmedico.in. You are requested to kindly take the same on your record and acknowledge receipt. PRISM MEDICO AND PHARMACY LTD. - 512217 - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
With reference to the above captioned subject report on investor complaints for the quarter ended 30th September, 2022 is as follows: Pending at the beginning of the quarter 0 (Zero) Received during the quarter 0 (Zero) Disposed off during the quarter 0 (Zero) Remaining unresolved at the end of the quarter 0 (Zero) You are requested to kindly take the same on your record and acknowledge receipt. PRISM MEDICO AND PHARMACY LTD. - 512217 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Davender SinghDesignation :- Any Other PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish a copy of compliance certificate issued by the RTA for the quarter ended 30th September, 2022. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. PRISM MEDICO AND PHARMACY LTD. - 512217 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report